scispace - formally typeset
T

Tae-Young Roh

Researcher at Pohang University of Science and Technology

Publications -  87
Citations -  18235

Tae-Young Roh is an academic researcher from Pohang University of Science and Technology. The author has contributed to research in topics: Chromatin immunoprecipitation & Epigenomics. The author has an hindex of 31, co-authored 79 publications receiving 16483 citations. Previous affiliations of Tae-Young Roh include National Institutes of Health.

Papers
More filters
Journal ArticleDOI

High-resolution profiling of histone methylations in the human genome.

TL;DR: High-resolution maps for the genome-wide distribution of 20 histone lysine and arginine methylations as well as histone variant H2A.Z, RNA polymerase II, and the insulator binding protein CTCF across the human genome using the Solexa 1G sequencing technology are generated.
Journal ArticleDOI

Combinatorial patterns of histone acetylations and methylations in the human genome

TL;DR: The data suggest that a large number of histone modifications may act cooperatively to prepare chromatin for transcriptional activation and be associated with promoters and enhancers.
Journal ArticleDOI

Dynamic Regulation of Nucleosome Positioning in the Human Genome

TL;DR: It is found that nucleosome phasing relative to the transcription start sites is directly correlated to RNA polymerase II (Pol II) binding and the first nucleosomes downstream of a start site exhibits differential positioning in active and silent genes.
Journal ArticleDOI

Global Mapping of H3K4me3 and H3K27me3 Reveals Specificity and Plasticity in Lineage Fate Determination of Differentiating CD4+ T Cells

TL;DR: Although modifications of signature-cytokine genes (Ifng, Il4, and Il17) partially conform to the expectation of lineage commitment, genes encoding transcription factors like Tbx21 exhibit a broad spectrum of epigenetic states, consistent with the demonstrated T-bet and interferon-gamma induction in nTreg cells.
Journal ArticleDOI

Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors

TL;DR: Bioinspired exosome-mimetic nanovesicles that deliver chemotherapeutics to the tumor tissue after systemic administration and removal of the plasma membrane proteins by trypsinization eliminated the therapeutic effects of the nanovesicle both in vitro and in vivo are suggested.